Universal Biosensors (ASX:UBI) has appointed Graham McLean as the new Chairman of the Board.
He has extensive experience in the medical technology industry, with his most recent role being President Asia Pacific at Stryker Corporation.
UBI has made significant changes to the way it conducts its business, including upgrading the Senior Management Team, clarifying its business strategy, and strengthening its capital settings.
UBI's ambition is to build a multi-product stable of biosensors in large markets.
Mr McLean and the Board are confident they have the experience and talent necessary to execute these innovative opportunities while Craig Coleman, previous Chairman, will remain on the board as a Non-Executive Director.